Prescription Monitoring Program Mandates and Opioids Dispensed to Patients Dying of Cancer
Comprehensive PDMP mandates were associated with modest reductions in opioid analgesics dispensed to Medicare patients dying of cancer. Non-Hispanic Black and Asian/Pacific Islander decedents experienced larger reductions.
Authors
- Judith A. Paice (ORCID: https://orcid.org/0000-0001-7534-1756)
- R. Portenoy
- Rulla M Tamimi
- Laura C. Pinheiro
- Yuhua Bao
- Ju-Chen Hu
- William E. Rosa
- M. Carrington Reid
- Yiye Zhang
- Fang Zhang
- Eduardo Bruera
- Hao Zhang
Institutions
- Northwestern University (US)
- Tulane University (US)
- Albert Einstein College of Medicine (US)
- Alabama Department of Public Health (US)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Cornell University (US)
- University of Alabama at Birmingham (US)
- Harvard Pilgrim Health Care (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1200/op-25-00187
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00